Toledo SR - Search Results

1

Aberrant signaling pathways in medulloblastomas: a stem cell connection.

Rodini CO, Suzuki DE, Nakahata AM, Pereira MC, Janjoppi L, Toledo SR, Okamoto OK. Rodini CO, et al. Among authors: toledo sr. Arq Neuropsiquiatr. 2010 Dec;68(6):947-52. doi: 10.1590/s0004-282x2010000600021. Arq Neuropsiquiatr. 2010. PMID: 21243257 Free article. Review.

2

Bone deposition, bone resorption, and osteosarcoma.

Toledo SR, Oliveira ID, Okamoto OK, Zago MA, de Seixas Alves MT, Filho RJ, Macedo CR, Petrilli AS. Toledo SR, et al. J Orthop Res. 2010 Sep;28(9):1142-8. doi: 10.1002/jor.21120. J Orthop Res. 2010. PMID: 20225287 Free article.

3

Insights on PRAME and osteosarcoma by means of gene expression profiling.

Toledo SR, Zago MA, Oliveira ID, Proto-Siqueira R, Okamoto OK, Severino P, Vêncio RZ, Gamba FT, Silva WA, Moreira-Filho CA, Torre CA, Alves MT, Garcia-Filho RJ, Simpson AJ, Petrilli AS. Toledo SR, et al. J Orthop Sci. 2011 Jul;16(4):458-66. doi: 10.1007/s00776-011-0106-7. Epub 2011 Jun 21. J Orthop Sci. 2011. PMID: 21691740

4

Expression analysis of stem cell-related genes reveal OCT4 as a predictor of poor clinical outcome in medulloblastoma.

Rodini CO, Suzuki DE, Saba-Silva N, Cappellano A, de Souza JE, Cavalheiro S, Toledo SR, Okamoto OK. Rodini CO, et al. Among authors: toledo sr. J Neurooncol. 2012 Jan;106(1):71-9. doi: 10.1007/s11060-011-0647-9. Epub 2011 Jul 2. J Neurooncol. 2012. PMID: 21725800

5

SHH, WNT, and NOTCH pathways in medulloblastoma: when cancer stem cells maintain self-renewal and differentiation properties.

Cordeiro BM, Oliveira ID, Alves MT, Saba-Silva N, Capellano AM, Cavalheiro S, Dastoli P, Toledo SR. Cordeiro BM, et al. Among authors: toledo sr. Childs Nerv Syst. 2014 Jul;30(7):1165-72. doi: 10.1007/s00381-014-2403-x. Epub 2014 Apr 3. Childs Nerv Syst. 2014. PMID: 24695855

6

MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.

Lopes LJS, Tesser-Gamba F, Petrilli AS, de Seixas Alves MT, Garcia-Filho RJ, Toledo SRC. Lopes LJS, et al. Mol Carcinog. 2017 Jun;56(6):1630-1641. doi: 10.1002/mc.22619. Epub 2017 Feb 15. Mol Carcinog. 2017. PMID: 28112450

7

Valproic acid treatment response in vitro is determined by TP53 status in medulloblastoma.

Mascaro-Cordeiro B, Oliveira ID, Tesser-Gamba F, Pavon LF, Saba-Silva N, Cavalheiro S, Dastoli P, Toledo SRC. Mascaro-Cordeiro B, et al. Childs Nerv Syst. 2018 Aug;34(8):1497-1509. doi: 10.1007/s00381-018-3817-7. Epub 2018 May 22. Childs Nerv Syst. 2018. PMID: 29785653

8

MAPK7 and MAP2K4 as prognostic markers in osteosarcoma.

Tesser-Gamba F, Petrilli AS, de Seixas Alves MT, Filho RJ, Juliano Y, Toledo SR. Tesser-Gamba F, et al. Among authors: toledo sr. Hum Pathol. 2012 Jul;43(7):994-1002. doi: 10.1016/j.humpath.2011.08.003. Epub 2011 Dec 9. Hum Pathol. 2012. PMID: 22154052

9

Investigation of PAX3/7-FKHR fusion genes and IGF2 gene expression in rhabdomyosarcoma tumors.

de Souza RR, Oliveira ID, Caran EM, Alves MT, Abib S, Toledo SR. de Souza RR, et al. Among authors: toledo sr. Growth Horm IGF Res. 2012 Dec;22(6):245-9. doi: 10.1016/j.ghir.2012.07.003. Epub 2012 Oct 16. Growth Horm IGF Res. 2012. PMID: 23079386

10

Analysis of KIAA1549-BRAF fusion gene expression and IDH1/IDH2 mutations in low grade pediatric astrocytomas.

Cruz GR, Dias Oliveira I, Moraes L, Del Giudice Paniago M, de Seixas Alves MT, Capellano AM, Saba-Silva N, Cavalheiro S, Cerutti JM, Toledo SR. Cruz GR, et al. Among authors: toledo sr. J Neurooncol. 2014 Apr;117(2):235-42. doi: 10.1007/s11060-014-1398-1. Epub 2014 Feb 17. J Neurooncol. 2014. PMID: 24532263

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page